v3.26.3
BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
USD ($)
Sep. 30, 2025
Sep. 30, 2026
USD ($)
contracts
Sep. 30, 2025
Dec. 31, 2025
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]          
Number of Reportable Segments | contracts     2    
Disaggregation of Revenue [Line Items]          
Percent of Revenue Contributed 100.00% 100.00% 100.00% 100.00%  
Ownership percentage below which investments are generally accounted for on the cost method (in thousandths)     20.00%    
Investments | $ $ 226.3   $ 226.3   $ 201.9
Diagnostics          
Disaggregation of Revenue [Line Items]          
Percent of Revenue Contributed 77.00% 78.00% 78.00% 78.00%  
Biopharma Laboratory Services          
Disaggregation of Revenue [Line Items]          
Percent of Revenue Contributed 23.00% 22.00% 22.00% 22.00%